Overview

Lorazepam-Induced Toxicity in the Aged

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the effects of an acute dose of lorazepam to a placebo in elderly patients with generalized anxiety disorder (GAD).
Phase:
Phase 4
Details
Lead Sponsor:
Nathan Kline Institute for Psychiatric Research
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Lorazepam